1,312 research outputs found

    Dynamical Structure Factor of the Three-Dimensional Quantum Spin Liquid Candidate NaCaNi2F7

    No full text
    We study the dynamical structure factor of the spin-1 pyrochlore material NaCaNi2F7, which is well described by a weakly perturbed nearest-neighbour Heisenberg Hamiltonian, Our three approaches- molecular dynamics simulations, stochastic dynamical theory, and linear spin wave theory-reproduce remarkably well the momentum dependence of the experimental inelastic neutron scattering intensity as well as its energy dependence with the exception of the lowest energies. We discuss two surprising aspects and their implications for quantum spin liquids in general: the complete lack of sharp quasiparticle excitations in momentum space and the success of the linear spin wave theory in a regime where it would be expected to fail for several reasons

    The timed barium swallow and its relationship to symptoms in achalasia: Analysis of surface area and emptying rate

    Get PDF
    BACKGROUND: Timed barium swallow (TBS) is used to objectively measure response following achalasia therapy; however, findings can be discordant with symptoms. We hypothesized that measurement of surface area of the residual barium column would improve its utility in measuring outcome. METHODS: In a single-center cohort, achalasia patients undergoing therapy between September 2015-2016 who had TBS were included. Four metrics of emptying were studied: Post-therapy residual barium (a) absolute height and (b) surface area and percentage reduction in (c) residual height (%H) and (d) surface area (%SA) compared to pretherapy. Metrics were evaluated against symptom response (Eckardt score). KEY RESULTS: Twenty-four achalasics (median age 43 year; 13 males) were included; 14 received pneumatic dilatation, and 10 had peroral endoscopic myotomy. Treatment resulted in significant reduction in median Eckardt score (7 to 1; P = .03), mean residual barium column height (14.7 ± 8.7 to 7.9 ± 6.0 cm; P = .01) and surface area (52.7 ± 43.5 to 24.5 ± 23.6 cm2 ; P = .02). There were 4 (17%) initial non-responders (Eckardt > 3). % SA was best at discriminating between responders and non-responders (area under curve 0.85 ± 0.08; sensitivity 100%, specificity 80%). Concordance with symptomatic response following therapy was 83% when using 45% as the cutoff for surface area reduction compared to pretherapy. Eight patients whose static barium height was discordant with symptoms became concordant when % SA was used as a measure of response. CONCLUSIONS & INFERENCES: Change in barium surface area is a superior measure of esophageal emptying and better correlates with treatment response than the conventional 5-minute barium height in defining objective response to achalasia therapy

    Polar ozone

    Get PDF
    The observation and interpretation of a large, unexpected ozone depletion over Antarctica has changed the international scientific view of stratospheric chemistry. The observations which show the veracity, seasonal nature, and vertical structure of the Antarctic ozone hole are presented. Evidence for Arctic and midlatitude ozone loss is also discussed. The chemical theory for Antarctic ozone depletion centers around the occurrence of polar stratospheric clouds (PSCs) in Antarctic winter and spring; the climatology and radiative properties of these clouds are presented. Lab studies of the physical properties of PSCs and the chemical processes that subsequently influence ozone depletion are discussed. Observations and interpretation of the chemical composition of the Antarctic stratosphere are described. It is shown that the observed, greatly enhanced abundances of chlorine monoxide in the lower stratosphere are sufficient to explain much if not all of the ozone decrease. The dynamic meteorology of both polar regions is given, interannual and interhemispheric variations in dynamical processes are outlined, and their likely roles in ozone loss are discussed

    Performance and evaluation in computed tomographic colonography screening: protocol for a cluster randomised trial

    Get PDF
    Background: Colorectal cancer (CRC) is a common, important healthcare priority and improving patient outcome relies on early diagnosis. Colonoscopy and computed tomographic colonography (CTC) are commonly-used diagnostic tests. Although colonoscopists are highly regulated and must be accredited, no analogous process exists for CTC. There are currently no universally accepted radiologist performance indicators for CTC, and lack of regulatory oversight may lead to variability in quality and lower neoplasia detection rates. This study aims to determine whether a structured educational training and feedback programme can improve radiologist interpretation accuracy. / Methods: NHS England CTC reporting radiologists will be cluster randomised to either an intervention (one-day individualised training and assessment with feedback) or control (assessment with no training or feedback) arm. Each cluster represents radiologists reporting CTC in a single NHS site. Both the intervention and control arm will undertake four CTC assessments at baseline, 1-month (after training; intervention arm or enrolment; control arm), 6- and 12 months to assess their detection of colorectal cancer (CRC) and 6mm+ polyps. The primary outcome will be difference in sensitivity at the 1-month test between arms. Secondary outcomes will include sensitivity at 6 and 12 months and radiologist characteristics associated with improved performance. Multilevel logistic regression will be used to analyse per-polyp and per-case sensitivity. Local ethical and Health Research Authority approval have been obtained. / Discussion: Lack of infrastructure to ensure that CTC radiologists can report adequately and lack of consensus regarding appropriate quality metrics may lead to variability in performance. Our provision of a structured education programme with feedback will evaluate the impact of individualised training and identify the factors related to improved radiologist performance in CTC reporting. An improvement in performance could lead to increased neoplasia detection and better patient outcome. / Registration: Clinical Trials (ClinicalTrials.gov Identifier: NCT02892721); available from: https://clinicaltrials.gov/ct2/show/NCT02892721. NIHR Clinical Research Network (CPMS ID 32293)
    • …
    corecore